AXDX insider trading

Accelerate Diagnostics, Inc: insider trade history from SEC Form 4 filings.

Total Form 4 trades
389
Last 90 days
0
Buys / sells
39% / 19%
Market cap
—

AXDX insider activity at a glance

FilingIQ tracks 389 insider transactions for AXDX in filings since Jan 5, 2015. The most recent transaction is dated Apr 4, 2025.

Across the full history, 153 open-market purchases and 73 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AXDX insider trades is 56.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest AXDX Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Top insiders trading AXDX

Frequently asked

How many insider trades does FilingIQ track for AXDX?
FilingIQ tracks 389 Form 4 insider transactions for AXDX (Accelerate Diagnostics, Inc), covering filings from Jan 5, 2015 onwards. 0 of those are dated within the last 90 days.
Are AXDX insiders net buyers or net sellers?
Across the full Form 4 history for AXDX, 153 transactions (39%) were open-market purchases and 73 (19%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AXDX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

Methodology & sources

Every AXDX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.